Current Assets
Raw materials
Amgen Raw materials increased by 14.5% to $1.05B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.6%, from $841M to $1.05B. Over 5 years (FY 2020 to FY 2025), Raw materials shows an upward trend with a 13.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2015
Last reportedQ1 2026Apr 30, 2026
Parent metricInventories
Metric ID:
inv_raw_materialsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $641M | $667M | $647M | $750M | $779M | $801M | $828M | $903M | $855M | $849M | $993M | $928M | $884M | $788M | $818M | $841M | $885M | $955M | $915M | $1.05B |
| QoQ Change | — | +4.1% | -3.0% | +15.9% | +3.9% | +2.8% | +3.4% | +9.1% | -5.3% | -0.7% | +17.0% | -6.5% | -4.7% | -10.9% | +3.8% | +2.8% | +5.2% | +7.9% | -4.2% | +14.5% |
| YoY Change | — | — | — | — | +21.5% | +20.1% | +28.0% | +20.4% | +9.8% | +6.0% | +19.9% | +2.8% | +3.4% | -7.2% | -17.6% | -9.4% | +0.1% | +21.2% | +11.9% | +24.6% |
| % of Inventories | 15.6% | 16.1% | 15.8% | 17.0% | 17.1% | 16.8% | 16.8% | 18.0% | 17.2% | 16.9% | 10.4% | 10.6% | 11.1% | 10.7% | 11.7% | 12.5% | 13.4% | 15.0% | 14.7% | 16.9% |
| Share Change | — | +0.5pp | -0.2pp | +1.2pp | +0.1pp | -0.3pp | -0.0pp | +1.2pp | -0.8pp | -0.3pp | -6.5pp | +0.2pp | +0.4pp | -0.4pp | +1.0pp | +0.8pp | +0.9pp | +1.6pp | -0.4pp | +2.2pp |
Range$641M – $1.05B
CAGR+10.9%
Avg YoY Growth+9.7%
Median YoY Growth+10.8%
Raw materials at Other Companies
Frequently Asked Questions
- What is Amgen's raw materials?
- Amgen (AMGN) reported raw materials of $1.05B in Q1 2026.
- How has Amgen's raw materials changed year-over-year?
- Amgen's raw materials increased by 24.6% year-over-year, from $841M to $1.05B.
- What is the long-term trend for Amgen's raw materials?
- Over 5 years (2020 to 2025), Amgen's raw materials has grown at a 13.5% compound annual growth rate (CAGR), from $486M to $915M.